BIOMAT Database Logo BIOMAT Database Logo

Platelet antiaggregants in pregnancy. 2009

Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011249 Pregnancy Complications, Cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Cardiovascular Pregnancy Complications,Complications, Cardiovascular Pregnancy,Pregnancy, Cardiovascular Complications,Cardiovascular Pregnancy Complication,Complication, Cardiovascular Pregnancy,Pregnancies, Cardiovascular Complications,Pregnancy Complication, Cardiovascular
D003328 Coronary Thrombosis Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION. Thrombosis, Coronary,Coronary Thromboses,Thromboses, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077144 Clopidogrel A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION. Clopidogrel Besilate,Clopidogrel Besylate,Clopidogrel Bisulfate,Clopidogrel Hydrochloride,Clopidogrel Napadisilate,Clopidogrel Sandoz,Clopidogrel, (+)(S)-isomer,Clopidogrel-Mepha,Iscover,PCR 4099,PCR-4099,Plavix,SC 25989C,SC 25990C,SR 25989,Clopidogrel Mepha
D000077284 Abciximab A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory unstable angina, and for prevention of ischemic complications in patients undergoing percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting. CentoRx,Chimeric 7E3 Fab,Clotinab,ReoPro,c7E3 Fab,Fab, Chimeric 7E3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants].
May 1985, Soins; la revue de reference infirmiere,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants].
July 2000, Medicina clinica,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants].
November 1990, La Revue du praticien,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants].
January 1991, Journal de pharmacie de Belgique,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants in cardiopathies].
January 1992, Archivos del Instituto de Cardiologia de Mexico,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet aggregation and platelet antiaggregants].
July 1987, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants and arteriopathies].
January 1981, Journal des maladies vasculaires,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants in other pathologies].
November 1989, La Revue du praticien,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
[Platelet antiaggregants in cardiovascular pathology].
January 1987, Revista de medicina de la Universidad de Navarra,
Pablo Santiago-Díaz, and Antonio L Arrebola-Moreno, and José A Ramírez-Hernández, and Rafael Melgares-Moreno
Platelet antiaggregants in stroke prevention.
August 2013, Neurologic clinics,
Copied contents to your clipboard!